Delivery Order SPE2DB20D1004-SPE2DB25FNGWG

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,205.36 firm fixed-price delivery order is for the supply of DEXCOM G7 SENSORS, a medical device used in the treatment of diabetes. The contract has an ultimate completion date of May 9, 2025 and is not set aside for any special business category. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,578.00 firm fixed-price delivery order is for the supply of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.24 firm fixed-price delivery order is for the procurement of DEXCOM G7 SENSORS, a medical device used for diabetes management. The award has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,193.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. This is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside and represents open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,295.37 firm-fixed-price delivery order is for the supply of DEXCOM G7 SENSORS, a type of medical device. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,727.73 firm fixed-price delivery order is for DEXCOM G7 SENSORS, a medical supply item. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $2,439.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. This is a firm fixed-price delivery order contract with a period of performance through December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $5,878.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for the management of diabetes. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,055.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award, valued at $1,559.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DEXCOM G7 SENSORS. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNGWG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,031.20 firm-fixed-price delivery order is for the supply of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract has a period of performance through May 8, 2025 and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/10/25, 1:06 AM